A clinical study of Medtronic's Reveal XT cardiac monitor is superior to conventional follow-up in identifying atrial fibrillation after cryptogenic stroke.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lZCY9M
Cap comentari:
Publica un comentari a l'entrada